InsiderFlow

LXEO

Lexeo Therapeutics, Inc. Common Stock$5.77+0.14 (+2.58%)
Prev Close$5.63·MCap$433.4M·P/E·Vol274.8K·Yield

Buys (12M)

0

$0.00

Sells (12M)

6

$488.3K

Net Activity

Net Seller

$488.3K

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at Lexeo Therapeutics, Inc. Common Stock (LXEO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $488.3K. The most recent insider transaction was by Townsend Richard Nolan (director, officer: Chief Executive Officer), who sold $313.1K worth of shares on Apr 7, 2026. Lexeo Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $433.4M.

LXEO Insider Trading Activity

DateInsiderTypeValue
Apr 7, 2026 Townsend Richard NolanSell$313.1K
Feb 20, 2026 Otero Jose ManuelSell$19.3K
Feb 20, 2026 Townsend Richard NolanSell$64.9K
Feb 18, 2026 Otero Jose ManuelSell$19.3K
Feb 18, 2026 Townsend Richard NolanSell$64.9K
Nov 18, 2025 Otero Jose ManuelSell$6.7K
Feb 21, 2025 Adler EricSell$10.4K
Feb 21, 2025 Robertson JennySell$9.3K
Dec 12, 2024 Townsend Richard NolanSell$20.5K
Nov 26, 2024 CHOLMONDELEY PAULA HBuy$104.9K
Nov 13, 2024 Townsend Richard NolanSell$19.6K
Oct 15, 2024 Townsend Richard NolanSell$40.5K
Sep 11, 2024 Townsend Richard NolanSell$53.3K
Aug 13, 2024 Townsend Richard NolanSell$57.6K
Jul 12, 2024 Townsend Richard NolanSell$923.4K
Jun 12, 2024 Townsend Richard NolanSell$88.3K
May 14, 2024 Townsend Richard NolanSell$66.1K
Nov 9, 2023 Longitude Capital Partners IV, LLCBuy$5.00M0.6% OS
Nov 9, 2023 Lundbeckfond Invest A/SBuy$2.50M
Nov 9, 2023 Omega Fund VI, L.P.Buy$5.00M0.6% OS

LXEO Insider Buying Activity

The following table shows recent insider purchases of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 26, 2024 CHOLMONDELEY PAULA HBuy$104.9K
Nov 9, 2023 Longitude Capital Partners IV, LLCBuy$5.00M0.6% OS
Nov 9, 2023 Lundbeckfond Invest A/SBuy$2.50M
Nov 9, 2023 Omega Fund VI, L.P.Buy$5.00M0.6% OS

LXEO Insider Selling Activity

The following table shows recent insider sales of Lexeo Therapeutics, Inc. Common Stock (LXEO) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Apr 7, 2026 Townsend Richard NolanSell$313.1K
Feb 20, 2026 Otero Jose ManuelSell$19.3K
Feb 20, 2026 Townsend Richard NolanSell$64.9K
Feb 18, 2026 Otero Jose ManuelSell$19.3K
Feb 18, 2026 Townsend Richard NolanSell$64.9K
Nov 18, 2025 Otero Jose ManuelSell$6.7K
Feb 21, 2025 Adler EricSell$10.4K
Feb 21, 2025 Robertson JennySell$9.3K
Dec 12, 2024 Townsend Richard NolanSell$20.5K
Nov 13, 2024 Townsend Richard NolanSell$19.6K
Oct 15, 2024 Townsend Richard NolanSell$40.5K
Sep 11, 2024 Townsend Richard NolanSell$53.3K
Aug 13, 2024 Townsend Richard NolanSell$57.6K
Jul 12, 2024 Townsend Richard NolanSell$923.4K
Jun 12, 2024 Townsend Richard NolanSell$88.3K
May 14, 2024 Townsend Richard NolanSell$66.1K

LXEO Insiders

Townsend Richard Nolan

director, officer: Chief Executive Officer

Sold $1.71M
11 tradesLast: Apr 7, 2026
Otero Jose Manuel

officer: Chief Operating Officer

Sold $45.3K
3 tradesLast: Feb 20, 2026
Robertson Jenny

Chief Legal Officer

Sold $9.3K
1 tradesLast: Feb 21, 2025
Adler Eric

Chief Medical Officer

Sold $10.4K
1 tradesLast: Feb 21, 2025
CHOLMONDELEY PAULA H

Bought $104.9K
1 tradesLast: Nov 26, 2024
Lundbeckfond Invest A/S

10% Owner

Bought $2.50M
1 tradesLast: Nov 9, 2023
Omega Fund VI, L.P.

10% Owner

Bought $5.00M
1 tradesLast: Nov 9, 2023
Longitude Capital Partners IV, LLC

10% Owner

Bought $5.00M
1 tradesLast: Nov 9, 2023